Isoflurane attenuates dynorphin-induced cytotoxicity and downregulation of Bcl-2 expression in differentiated neuroblastoma SH-SY5Y cells

Acta Anaesthesiologica Scandinavica

Volumn 53, Issue 1, 2009, Pages 55-60

  Wu, G J ^a,b   Chen, W F ^c   Sung, C S ^d   Jean, Y H ^e   Hung, C H ^e   Chen, F A ^f   Hsieh, M H ^f   Wen, Z H ^g  

^a SHIN KONG WU HO SU MEMORIAL HOSPITAL   (Taiwan)

^b FU JEN CATHOLIC UNIVERSITY   (Taiwan)

^c CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

^d NATIONAL YANG MING UNIVERSITY   (Taiwan)

^e PINGTUNG CHRISTIAN HOSPITAL   (Taiwan)

^f TAJEN UNIVERSITY   (Taiwan)

^g NATIONAL SUN YAT SEN UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

DYNORPHIN; ISOFLURANE; PROTEIN BCL 2; RETINOIC ACID;

APOPTOSIS; ARTICLE; CELL DIFFERENTIATION; CELL SURVIVAL; CELL VIABILITY; CONTROLLED STUDY; CYTOTOXICITY; DOWN REGULATION; DRUG EFFECT; HUMAN; HUMAN CELL; NERVE CELL CULTURE; NEUROBLASTOMA CELL; NEUROPROTECTION; NICK END LABELING; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; WESTERN BLOTTING;

APOPTOSIS; CELL DIFFERENTIATION; CELL LINE, TUMOR; DOWN-REGULATION; DYNORPHINS; HUMANS; ISOFLURANE; NEUROBLASTOMA; PROTO-ONCOGENE PROTEINS C-BCL-2;

EID: 57649217571     PISSN: 00015172     EISSN: 13996576     Source Type: Journal    
DOI: 10.1111/j.1399-6576.2008.01828.x     Document Type: Article

References (34)

1. Civelli OJ, Douglass A, Goldstein A, Herbert E. Sequence and expression of the rat prodynorphin gene. Proc Natl Acad Sci USA 1985 82 : 4291 5.
2. McIntosh TK, Head VA, Faden AI. Alterations in regional concentrations of endogenous opioids following traumatic brain injury in the cat. Brain Res 1987 425 : 225 33.
3. Johnson M, Hanson GR, Gibb JW, Adair J, Filloux F. Effect of neonatal hypoxia-ischemia on nigro-striatal dopamine receptors and on striatal neuropeptide Y, dynorphin A and substance P concentrations in rats. Brain Res Dev Brain Res 1994 83 : 109 18.
4. Simonato M, Romualdi P. Dynorphin and epilepsy. Prog Neurobio 1997 51 : 223 4.
5. Gardell LR, Vanderah TW, Gardell SE, Wang R, Ossipov MH, Lai J, Porreca F. Enhanced evoked excitatory transmitter release in experimental neuropathy requires descending facilitation. J Neurosci 2003 23 : 8370 9.
6. Long JB, Rigamonti DD, de Costa B, Rice KC, Martinez-Arizala A. Dynorphin A-induced rat hindlimb paralysis and spinal cord injury are not altered by the kappa opioid antagonist nor-binaltorphimine. Brain Res 1989 497 : 155 62.
7. Hauser KF, Folds JK, Turbek CS. Dynorphin A (1-13) neurotoxicity in vitro: opioid and non opioid mechanisms in mouse spinal cord neurons. Exp Neurol 1999 160 : 361 75.
8. Redell JB, Moore AN, Dash PK. Expression of the prodynorphin gene after experimental brain injury and its role in behavioral dysfunction. Exp Biol Med 2003 228 : 261 9.
9. Faden AI. Dynorphin increases extracellular levels of excitatory amino acids in the brain through a non-opioid mechanism. J Neurosci 1992 12 : 425 9.
10. Isaac L, Van Zandt O'Malley T, Ristic H, Stewart P. MK-801 blocks dynorphin A (1-13)-induced loss of the tail-flick reflex in the rat. Brain Res 1990 531 : 83 7.
11. Singh IN, Goody RJ, Goebel SM, Martin KM, Knapp PE, Marinova Z, Hirschberg D, Yakovleva T, Bergman T, Bakalkin G, Hauser KF. Dynorphin A (1-17) induces apoptosis in striatal neurons in vitro through alpha-amino-3-hydroxy-5- methylisoxazole-4-propionate/kainate receptor-mediated cytochrome c release and caspase-3 activation. Neuroscience 2003 122 : 1013 23.
12. Tsujimoto Y, Finger LR, Yunis J, Nowell PC, Croce CM. Cloning of the chromosome breakpoint of neoplastic B cells with the t (14 : 18) chromosome translocation. Science 1984 90 : 4533 7.
13. Merry DE, Korsmeyer SJ. Bcl-2 gene family in the nervous system. Annu Rev Neurosci 1997 20 : 245 67.
14. Ghribi O, Herman MM, Spaulding NK, Savory J. Lithium inhibits aluminum-induced apoptosis in rabbit hippocampus, by preventing cytochrome c translocation, Bcl-2 decrease, Bax elevation and caspase-3 activation. J Neurochem 2002 82 : 137 45.
15. Pérez-Navarro E, Gavaldà N, Gratacòs E, Alberch J. Brain-derived neurotrophic factor prevents changes in Bcl-2 family members and caspase-3 activation induced by excitotoxicity in the striatum. J Neurochem 2005 92 : 678 91.
16. Eberspächer E, Werner C, Engelhard K, Pape M, Laacke L, Winner D, Hollweck R, Hutzler P, Kochs E. Long-term effects of hypothermia on neuronal cell death and the concentration of apoptotic proteins after incomplete cerebral ischemia and reperfusion in rats. Acta Anaesthesiol Scand 2005 49 : 477 87.
17. Kapinya KJ, Lowl D, Futterer C, Maurer M, Waschke KF, Isaev NK, Dirnagl U. Tolerance against ischemic neuronal injury can be induced by volatile anesthetics and is inducible NO synthase dependent. Stroke 2002 33 : 1889 98.
18. Zheng S, Zuo Z. Isoflurane preconditioning reduces purkinje cell death in an in vitro model of rat cerebellar ischemia. Neuroscience 2003 118 : 99 106.
19. Huang Y, Zuo Z. Effects of isoflurane on oxygen-glucose deprivation-induced changes of gene expression profiling in glial-neuronal cocultures. Acta Anaesthesiol Scand 2005 49 : 1544 51.
20. Bickler PE, Buck LT, Feiner JR. Volatile and intravenous anesthetic decrease glutamate release form cortical brain slices during anoxia. Anesthesiology 1995 83 : 1230 40.
21. Kawaguchi M, Drummond JC, Cole DJ, Kelly PJ, Spurlock MP, Patel PM. Effect of isoflurane on neuronal apoptosis in rats subjected to focal cerebral ischemia. Anesth Analg 2004 98 : 798 805.
22. Zuo Z, Wang Y, Huang Y. Isoflurane preconditioning protects human neuroblastoma SH-SY5Y cells against in vitro simulated ischemia-reperfusion through the activation of extracellular signal-regulated kinases pathway. Eur J Pharmacol 2006 542 : 84 91.
23. Nishizawa Y. Glutamate release and neuronal damage in ischemia. Life Sci 2001 69 : 369 81.
24. Sattler R, Tymianki M. Molecular mechanisms of glutamate receptor-mediated excitotoxic neuronal cell death. Mol Neurobiol 2001 24 : 107 29.
25. Skilling SR, Sun X, Kurtz HJ, Larson AA. Selective potentiation NMDA-induced activity and release of excitatory amino acids by dynorphin: possible roles in paralysis and neurotoxicity. Brain Res 1992 575 : 272 8.
26. Koetzner L, Hua XY, Lai J, Porreca F, Yaksh T. Nonopioid actions of intrathecal dynorphin evoke spinal excitatory amino acid and prostaglandin E2 release mediated by cyclooxygenase-1 and -2. J Neurosci 2004 24 : 1451 8.
27. Shukla VK, Lemaire S. Non-opioid effects of dynorphins: possible role of NMDA receptor. Trends Pharmacol Sci 1994 15 : 420 24.
28. Raphael J, Abedat S, Rivo J, Meir K, Beeri R, Pugatsch T, Zuo Z, Gozal Y. Volatile anesthetic preconditioning attenuates myocardial apoptosis in rabbits after regional ischemia and reperfusion via Akt signaling and modulation of Bcl-2 family proteins. J Pharmacol Exp Ther 2006 318 : 186 94.
29. Wei H, Kang B, Wei W, Liang G, Meng QC, Li Y, Eckenhoff RG. Isoflurane and sevoflurane affect cell survival and BCL-2/BAX ratio differently. Brain Res 2005 1037 : 139 47.
30. Um M, Lodish HF. Antiapoptotic effects of erythropoietin in differentiated neuroblastoma SH-SY5Y cells require activation of both the STAT5 and AKT signaling pathways. J Biol Chem 2006 281 : 5648 56.
31. Bickler PE, Buck LT, Hansen BM. Effects of isoflurane and hypothermia on glutamate receptor-mediated calcium influx in brain slices. Anesthesiology 1994 81 : 1461 9.
32. Harada H, Kelly PJ, Cole DJ, Drummond JC, Patel PM. Isoflurane reduces N-methyl-D-aspartate toxicity in vivo in the rat cerebral cortex. Anesth Analg 1999 89 : 1442 7.
33. Kudo M, Aono M, Lee Y, Massey G, Pearlstein RD, Warner DS. Effects of volatile anesthetics on N-methyl-D-aspartate excitotoxicity in primary rat neuronal-glial cultures. Anesthesiology 2001 95 : 756 65.
34. Maclver MB, Mikulec AA, Amagasu SM, Monroe FA. Volatile anesthetics depress glutamate transmission via presynaptic actions. Anesthesiology 1996 85 : 823 34.